M3 Wake Research-Dallas

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Epilepsy2 trials
• Graves' disease and hyperthyroidism1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 23 trials
• Phase 1/21 trial
• Phase 2/31 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials
• Enrolling by invitation1 trial

Lead sponsor

• Biohaven Therapeutics Ltd.2 trials
• Biogen1 trial
• Corxel Pharmaceuticals1 trial
• COUR Pharmaceutical Development Company, Inc.1 trial

Running trials

• Recruiting

  A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

  NCT07722546· Phase 2· Biogen· Source

  Contact: Carlos Arauz-Pacheco (principal investigator)

• Active, not recruiting

  A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  NCT07340320· Phase 2· Corxel Pharmaceuticals· Source

• Recruiting

  CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  NCT06783309· Phase 1/2· COUR Pharmaceutical Development Company, Inc.· Source

  Contact: Vicki Martinez

• Enrolling by invitation

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· Phase 2· Biohaven Therapeutics Ltd.· Source

• Active, not recruiting

  Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  NCT06309966· Phase 2/3· Biohaven Therapeutics Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy1 recruiting
• Graves' disease and hyperthyroidism1 recruiting
• Type 1 diabetes1 recruiting